As director of corporate and commercial strategy, Tan developed, communicated and executed corporate and commercial strategic initiatives of the iX Group.
Speciality pharmaceutical company iX Biopharma has appointed Eva Tan as its new chief commercial officer.
Tan previously served as iX Biopharma’s director of corporate and commercial strategy since 2019, and commercial director from 2017 to 2019.
